US3886287A - Cosmetics containing saturated, branched synthetic higher hydrocarbon - Google Patents
Cosmetics containing saturated, branched synthetic higher hydrocarbon Download PDFInfo
- Publication number
- US3886287A US3886287A US363372A US36337273A US3886287A US 3886287 A US3886287 A US 3886287A US 363372 A US363372 A US 363372A US 36337273 A US36337273 A US 36337273A US 3886287 A US3886287 A US 3886287A
- Authority
- US
- United States
- Prior art keywords
- eicosane
- trimethylbutyl
- trimethyl
- octyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002430 hydrocarbons Chemical class 0.000 title claims abstract description 71
- 229930195733 hydrocarbon Natural products 0.000 title claims abstract description 64
- 239000002537 cosmetic Substances 0.000 title claims abstract description 50
- 239000004215 Carbon black (E152) Substances 0.000 title claims abstract description 24
- 229920006395 saturated elastomer Polymers 0.000 title claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 21
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 25
- -1 2,2,4-trimethyl-7-(1,3,3-trimethylbutyl)eicosane Chemical compound 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims description 16
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 claims description 8
- 231100000344 non-irritating Toxicity 0.000 claims description 5
- YADRUKHQINPUCI-UHFFFAOYSA-N 13,16-didecyloctacosane Chemical compound C(CCCCCCCCC)C(CCCCCCCCCCCC)CCC(CCCCCCCCCCCC)CCCCCCCCCC YADRUKHQINPUCI-UHFFFAOYSA-N 0.000 claims description 4
- 230000006872 improvement Effects 0.000 claims description 4
- ZYUFQRFTPSWMRA-UHFFFAOYSA-N 3,3,22,22-tetraethyltetracosane Chemical compound C(C)C(CCCCCCCCCCCCCCCCCCC(CC)(CC)CC)(CC)CC ZYUFQRFTPSWMRA-UHFFFAOYSA-N 0.000 claims description 3
- BSIFNZHXAJVEAD-UHFFFAOYSA-N 9,12-dihexylicosane Chemical compound C(CCCCC)C(CCCCCCCC)CCC(CCCCCCCC)CCCCCC BSIFNZHXAJVEAD-UHFFFAOYSA-N 0.000 claims description 3
- RNJKBJILLKREJB-UHFFFAOYSA-N 9-(3-ethylheptyl)nonadecane Chemical compound C(C)C(CCCC)CCC(CCCCCCCCCC)CCCCCCCC RNJKBJILLKREJB-UHFFFAOYSA-N 0.000 claims description 3
- BCJIIUWSRWQRFY-UHFFFAOYSA-N 9-hexyl-12-octyldocosane Chemical compound C(CCCCC)C(CCCCCCCC)CCC(CCCCCCCCCC)CCCCCCCC BCJIIUWSRWQRFY-UHFFFAOYSA-N 0.000 claims description 3
- CEYAECAIPFYPFO-UHFFFAOYSA-N 7-(4,4-dimethylpentan-2-yl)-10-ethyl-2,2,4-trimethyltetradecane Chemical compound CC(C)(CC(CCC(CCC(CCCC)CC)C(CC(C)(C)C)C)C)C CEYAECAIPFYPFO-UHFFFAOYSA-N 0.000 claims description 2
- QWTJJTSCKBRDBU-UHFFFAOYSA-N 11,14-dioctyltetracosane Chemical compound CCCCCCCCCCC(CCCCCCCC)CCC(CCCCCCCC)CCCCCCCCCC QWTJJTSCKBRDBU-UHFFFAOYSA-N 0.000 claims 2
- TVDHHWRMBSKMTD-UHFFFAOYSA-N 11-(3-ethylheptyl)tricosane Chemical compound C(C)C(CCCC)CCC(CCCCCCCCCCCC)CCCCCCCCCC TVDHHWRMBSKMTD-UHFFFAOYSA-N 0.000 claims 2
- VVYIWKRNBHOLEX-UHFFFAOYSA-N 12-decyl-9-hexyltetracosane Chemical compound C(CCCCC)C(CCCCCCCC)CCC(CCCCCCCCCCCC)CCCCCCCCCC VVYIWKRNBHOLEX-UHFFFAOYSA-N 0.000 claims 2
- XDQJMBAMPIMRPX-UHFFFAOYSA-N 14-decyl-11-octylhexacosane Chemical compound C(CCCCCCC)C(CCCCCCCCCC)CCC(CCCCCCCCCCCC)CCCCCCCCCC XDQJMBAMPIMRPX-UHFFFAOYSA-N 0.000 claims 2
- SGXCEJXQZRBHQH-UHFFFAOYSA-N 11-[3-(4,4-dimethylpentan-2-yl)-6,8,8-trimethylnonyl]tricosane Chemical compound CC(C)(CC(CCC(CCC(CCCCCCCCCCCC)CCCCCCCCCC)C(CC(C)(C)C)C)C)C SGXCEJXQZRBHQH-UHFFFAOYSA-N 0.000 claims 1
- GSYYFUPJIKODNM-UHFFFAOYSA-N 7-(4,4-dimethylpentan-2-yl)-2,2,4-trimethyl-10-octylicosane Chemical compound CC(C)(CC(CCC(CCC(CCCCCCCCCC)CCCCCCCC)C(CC(C)(C)C)C)C)C GSYYFUPJIKODNM-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract description 26
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 abstract description 11
- 229940032094 squalane Drugs 0.000 abstract description 11
- 239000000490 cosmetic additive Substances 0.000 abstract description 3
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 20
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 206010015150 Erythema Diseases 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 10
- 238000009835 boiling Methods 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 230000005484 gravity Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- POOSGDOYLQNASK-UHFFFAOYSA-N tetracosan acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC POOSGDOYLQNASK-UHFFFAOYSA-N 0.000 description 7
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 235000008935 nutritious Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 3
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 3
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 3
- NZWIYPLSXWYKLH-UHFFFAOYSA-N 3-(bromomethyl)heptane Chemical compound CCCCC(CC)CBr NZWIYPLSXWYKLH-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- LGZJJXVWGCAGKB-UHFFFAOYSA-N 7-(chloromethyl)pentadecane Chemical compound CCCCCCCCC(CCl)CCCCCC LGZJJXVWGCAGKB-UHFFFAOYSA-N 0.000 description 3
- XSQSDBVMLJNZKU-UHFFFAOYSA-N 9-(bromomethyl)nonadecane Chemical compound CCCCCCCCCCC(CBr)CCCCCCCC XSQSDBVMLJNZKU-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 101150065749 Churc1 gene Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102100038239 Protein Churchill Human genes 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 2
- LZKYWQWTXFXFQI-UHFFFAOYSA-N 5-(bromomethyl)-2,2,4,8,10,10-hexamethylundecane Chemical compound CC(C)(C)CC(C)CCC(CBr)C(C)CC(C)(C)C LZKYWQWTXFXFQI-UHFFFAOYSA-N 0.000 description 2
- RWEKWRQKAHQYNE-UHFFFAOYSA-N 7-(bromomethyl)pentadecane Chemical compound CCCCCCCCC(CBr)CCCCCC RWEKWRQKAHQYNE-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- XVTOMLAMPUXGPS-UHFFFAOYSA-N 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctan-1-ol Chemical compound CC(C)(C)CC(C)CCC(CO)C(C)CC(C)(C)C XVTOMLAMPUXGPS-UHFFFAOYSA-N 0.000 description 1
- DGQRNAPEPDFOEX-UHFFFAOYSA-N 5,8-diethyldodecane Chemical compound CCCCC(CC)CCC(CC)CCCC DGQRNAPEPDFOEX-UHFFFAOYSA-N 0.000 description 1
- DFVOXRAAHOJJBN-UHFFFAOYSA-N 6-methylhept-1-ene Chemical compound CC(C)CCCC=C DFVOXRAAHOJJBN-UHFFFAOYSA-N 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- HMSWAIKSFDFLKN-UHFFFAOYSA-N Hexacosane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCC HMSWAIKSFDFLKN-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000108056 Monas Species 0.000 description 1
- 241000918728 Monotes Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 238000006621 Wurtz reaction Methods 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000007037 hydroformylation reaction Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- HOWGUJZVBDQJKV-UHFFFAOYSA-N n-propyl-nonadecane Natural products CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C9/00—Aliphatic saturated hydrocarbons
- C07C9/22—Aliphatic saturated hydrocarbons with more than fifteen carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
Definitions
- the present invention relates to cosmetics, more par ticularly, relates to cosmetics containing as a cosmetic base, a synthetic higher hydrocarbon having excellent physiological properties.
- the conventional cosmetic contain a cosmetic base consisting of saturated higher hydrocarbons selected from higher mineral hydrocarbons, for example, liquid paraffins, higher animal hydrocarbons, for example, squalane which is prepared by completely hydrogenating squalene obtained from fish liver oil, and higher vegetable hydrocarbons, for instance, completely hydrogenated terpenes and polymerized terpenes.
- higher mineral hydrocarbons for example, liquid paraffins
- animal hydrocarbons for example, squalane which is prepared by completely hydrogenating squalene obtained from fish liver oil
- higher vegetable hydrocarbons for instance, completely hydrogenated terpenes and polymerized terpenes.
- the liquid mineral paraffins consist of a mixture of multiple component hydrocarbons, varying in molecular weight and chemical structure. Sometimes, some of the component hydrocarbons stimulate human skin and are easily decomposed by the action of microorganisms. Accordingly, the liquid paraffins guarantee little in cosmetic quality, that is, they neither ensure non-irritation to human skin nor stability during prolonged storage.
- the vegetable hydrocarbons also include a plurality of component hydrocarbons varying in number of carbon atoms and chemical structure. Therefore, the vegetable hydrocarbons sometimes include undesirable component hydrocarbons having considerable stimulating effect on human skin and low resistance to toggle-organisms.
- squalane is a simple higher animal hydrocarbon of 30 carbon atoms and does not stimulate human skin and has an excellent stability in storage.
- the squalane is prepared from squalene include in fish liver oil which is not always readily available, the supply of squalane is limited and variable in quantity.
- One object of the present invention is to provide cosmetics comprising, as a cosmetic base, a synthetic higher hydrocarbon having a non-stimulative property, a high stability to the action of micro-organisms, and other physiological properties.
- the other object of the present invention is to provide cosmetics, for example, skin, hair, make-up, bath and toilet cosmetics, comprising a cosmetic base effective for protecting the human body from the action of micro-organisms, with sufficient safety.
- the above-stated objects are accomplished by the cosmetics of the present invention.
- the cosmetics of the present invention comprise a base consisting of at least one saturated, branched synthetic higher hydrocarbon having 26 to 48 carbon atoms, of the formula:
- R,, R R and R represent an alkyl radical of 2 to 15 carbon atoms, but R, differs from R, and R, differs from R and other cosmetic additives.
- the synthetic higher hydrocarbons usable for the present invention are ideal for the cosmetic base.
- the synthetic higher hydrocarbons of the present invention can eliminate the above-mentioned drawbacks of the conventional cosmetic base, and be stored for a prolonged period without deterioration. Also, the synthetic higher hydrocarbons of the present invention are greatly effective for protecting human skin from chemical and physical stimulation, preventing the penetration of micro-organisms into the human body, and maintaining human skin in a normal physiological condition even if circumstance changes.
- Table 1 indicates physical properties of the typical synthetic higher hydrocarbons usable for the present invention. Further, Table 1 shows the physical properties of the synthetic hydrocarbons of less than 26 carbon atoms and squalane. namely, 2,6,10,15,19,23- hexamethyl-tetracosane.
- the synthetic higher hydrocarbons usable for the present invention include 26 to 48 carbon atoms.
- the hydrocarbons of less than 26 carbon atoms are not to be considered for the cosmetic base because of too low viscosity and excessive stimulation to human skin.
- the hydrocarbons having more than 48 carbon atoms are unsuitable for use as cosmetic base because of excessive viscosity and poor spreadability.
- the synthetic higher hydrocarbons usable for the present invention may be prepared by the conventional methods for synthesizing alkane compounds.
- the synthetic higher hydrocarbons may be prepared in accordance with the Wurtz reaction or Frankland reaction. That is, two saturated branched hydrocarbon halides of the formula:
- cacn x and xcn ca 1.
- 2,2,4-trimethyl-lO ethyl-7( l,3,3-trimethylbutyl)tetradecane and 2,2,4,13,15,]5-hexamethyl-7,l0-bis(1,3,3- trimethylbutyl)hexadecane The above mentioned hydrocarbon compounds were prepared by condensing Z-ethylexyl bromide and 5,7,7- trimethyl 2(l,3,3-trimethyl-butyl)octyl bromide.
- the lethylhexene-Z-al-l was prepared by condensing n'butylaldehyde in an aqueous solution of 2% by weight of sodium hydroxide, and then, converted to 2' ethylhexanol by hydrogenating in the presence of a raney nickel catalyst.
- a mixture of one mol of Z ethylhexanol and 2.1 mols of hydrobromic acid (which was an aqueous solution of more than 47% of hydrobromic acid, having a specific gravity of 1.48) was charged into a one litre, three neck flask, and then, 1 part by mol of concentrated sulfuric acid was added by drops while the flask contents were being cooled with ice.
- reaction mixture was gradually heated while stirring to a temperature of C and maintained at that temperature for 6 hours.
- the reaction product was diluted with hexane, successively washed with water, concentrated sulfuric acid, water and thereafter, an aqueous solution of sodium carbonate, dried over calcium chloride and then, distilled.
- the 5,7,7-trimethy1-2( 1,3 ,3-trimethyl-butyl)octy1 bromide was prepared by the following procedure.
- 3,5,5-trimethy1-hexyl aldehyde was prepared from isooctene by OXO synthesis (hydroformylation) and then, converted to 5,7,7-trimethyl-2(1,3,3-trimethylbutyl) octanol by the aldol condensation process.
- the 5,7,7-trimethy1-2(1,3,3-trimethyl-butyl) octanol was converted to butyl)octyl bromide having a boiling point of 120 128l2 mml'lg by reacting with the hydrobrornic acid in the same procedure as that of the Z-ethylhexyl bromide, in an yield of 72.7%.
- the condensation of the 2- ethylhexyl bromide with the 5,7,7-trimethyl-2 (1,3,3-trimethylbutyl)octyl bromide was effected by the following procedure.
- a 100 ml three neck flask was charged with a reaction mixture of 0.085 mol of the 2-ethylhexyl bromide and 0.085 mol of the 5,7,7-trimethyl-2( 1,3,3-triinethyl butyl)octyl bromide. 0.187 mol of metallic sodium was added to the reaction mixture, which was being cooled with ice and stirred for 5 hours under the cooled condition. The non-reacted metallic sodium was treated with methanol and water. The reaction product was dried with anhydrous sodium sulfate and then distilled to iso' late the resultant hydrocarbon compounds from each other.
- hydrocarbon compounds (B) and (C) thus obtained are novel compounds of the present invention and have the formulae (1) and (ll).
- 2-hexyl decanol was prepared from n-octylaldehyde in the same procedure as that of the 2-ethyl hexanol in Example 1.
- a reaction mixture of 2 mols of the 2- hexyldecanol and 3.mols of pyridine was charged into a 2 litre three neck flask and 2.4 mols of thiony] chloride were added by drops while the mixture was stirred and cooled with ice. After completing the addition of the thionyl chloride, the reaction mixture was heated at a temperature of 120 to 140C for 8 hours.
- the reaction product was diluted with hexane, successively washed with concentrated sulfuric acid, water and an aqueous solution of sodium carbonate, dried with anhydrous sodium sulfate and then distilled.
- 2-hexyldecyl chloride with a boiling point of l20 125C/3 mmHg was obtained in an amount of 276 g (yield: 53%).
- the 2-hexyldecyl chloride in an amount of 0.274 mol was charged into a 200 ml three neck reaction flask, 0.275 mol of metallic sodium was added, while stirring, at room temperature and then maintained at a temperature f l to 140C while stirring for 2 hours. Thereafter, the reaction mixture was heated at a temperature of 130C for 8 hours.
- the non-reacted metallic sodium was deactivated with ethanol,
- the reaction product was diluted with hexane, washed with water, dried with anhydrous sodium sulfate and then, distilled.
- boiling -dihexyl eicosane having 32 carbon atoms, a boiiling point of l 210C/l 2 mmHg, a viscosity at 25C of 31.5 cps, a specific gravity at 19C of 0.8230 and a freezing point of lower than 8.0C was obtained in a yield of 35%.
- the 9,12-dihexyl eicosane is a novel compound of the present invention and has the following formula I): cu.
- the 2-hexyldecyl bromide was prepared from 2 hexyl decanol using the same method as that of 2 ethylhexyl bromide in Example 1. i
- a 500 ml three neck reaction flask was charged with 0.l mol of metallic magnesium and a small amount of iodine, and a small amount ofthe 2-hexyldecyl bromide was added by drops. Thereafter, a solution of 0.2 mol of the Z-hexyldecyl bromide in 200 ml of anhydrous ether was further added by drops into the reaction flask. The reaction mixture was heated at a tempera ture of 55 65C for 24 hours while refluxing, and
- a mixture of 2-octyl dodecanol and the sodium salt of n'nonanoic acid was prepared by heating n-decanol at a temperature of 200 to 230C in the presence of sodium hydroxide. From the mixture, 2-octyl dodecanol was isolated by extraction and distillation. The 2-octyl dodecanol thus obtained, was converted to 2- octyldodecyl bromide having a boiling point of 175 185C/3 mml-lg by treating with hydrobromic acid in the same as that for 2-ethyl hexanol in Example 1.
- the condensation of the 2-octyldodecyl bromide was carried out by heating together with metallic sodium at room temperature for 16 hours, at 55C for 6 hours and then, at 150C for 4 hours.
- the condensation product was treated in the same method as that for the condensation product in Example I.
- 1 l ,14-dioctyl tetracosane having 40 carbon atoms, a boiling point of 200 220"C/' mml-lg, a viscosity at 25C, of 52.5 cps, a specific gravity at 19C of 0.8169 and a freezing point of 7.5 105C was obtained in a yield of 74%.
- the hydrocarbon compound thus prepared has the following formula IV:
- the lint pieces were covered by 3.5 cm square gauzes secured onto the test portions by adhesive tapes and further completely covered by rubber dams.
- the rabbits were maintained for 72 hours under the above-mentioned test conditions. After 24 hours the lint pieces on the rabbits were removed and the test portions were observed for red spots (erythemata) and dropsical swellings (edemata). The erythemata and edemata thus observed were valued in accordance with the predetermined evaluation standards as detailed hereinafter. Thereafter, the lint pieces were re-applied for the remaining 48 hours. After the testing was completed, the same evaluation as stated above was repeated.
- Table 2 clearly shows that the synthetic higher hydrocarbons of the present invention had practically no stimulation of animal skin. This is the same as that of squalane. However, the fluid paraft'me and the comparative hydrocarbons having less than 26 carbon atoms had high stimulation of animal skins.
- the synthetic higher hydrocarbons of the present invention as shown in Table 2 were further subjected to tests which might indicate stimulation of the mucous membranes of the eyes involving the cornea, iris and conjunctive which were observed at predetermined intervals of time. Also tests were carried out to observe effect on human skin and effects of acute toxicity resulting from ingestion of doses of 25 ml/kg body weight. All the results of the tests were negative. That is, the excellent safety of the synthetic higher hydrocarbons of the present invention was confirmed.
- culture medium 10 g hydrocarbon compound to be tested 2.5 g K2HPO4 0.5 g KH2PO4 0.3 g MgSO 0.3 g CaCI; 3.0 g (NH SO 0.3 g NaCl 1000 ml water 2.
- Culture condition 30 ml of culture medium was charged into a ml shaking flask sterilized in an autoclave at a high tem perature, and allowed to cool to room temperature.
- One platinum loop of the bacterial suspension was inoculated into the culture medium.
- the inoculated culture medium was shaken at a frequency of l20/minutes at a temperature of 30C for 7 days to culture the bacterium.
- the multiplication of the bacterial fungus bodies was determined by the method detailed below.
- the synthetic higher hydrocarbons of the present invention can be utilized as a cosmetic base for the treat ment and make-up products, such as O/W type nutritious cream, W/O type nutritious cream. pomade. lip stick, bath oil, skin lotion, skin moisturizer. eye make up and body lotion
- the cosmetics are prepared by making the synthetic higher hydrocarbon with the other cosmetic ingredients. for example, cctylalcohol. vaseline, lanoiine, polyoxyethylcne cetylalcohol ether. polyethylene glycol. bees war-1 soibitan monoolealc,
- the nutritious cream of the present example had cosmetic qualities similar to those of the comparison Cl'CLlr'T l.
- EXAMPLE 2 A W/G type nutritious cream was prepared by the following procedures.
- the resulting W/O type nutritious cream had excellent cosmetic properties.
- EXAMPLE 4 A pomade was prepared by the following method. 9% of 9.12-dihexyl eicosane was mixed with 52% of white vascline. 6% of solid paraffin and 30% of olive oil and the mixture was melted at a temperature of C while stirring. The melt was mixed with a necessary amount of coloring matter. The colored melt was allowed to cool to a temperature of 40 50C and mixed with 3% of a perfume and a necessary amount of an antioxidizing agent while stirring. The mixture was fed into a container and allowed to cool to room temperature.
- the resulting pomade was found to be satisfactory in cosmetic quality.
- R R R and R represent an alkyl radical of 2 to carbon atoms respectively, but R differs from R and R differs from R 2.
- said saturated, branched higher hydrocarbon is selected from the group consisting of 2,2,4-trimethy1-l0-ethy1-7-(1,3,3,- trimethylbutyl)tetradecane, 5-ethy1-8-octyloctadecane, 2,2,4-trimethyl-7-( 1,3,3-trimethylbutyl- )eicosane, 9,12-dihexyl-eicosane, hexaethyl-eicosane, S-ethyl-S-decyl-eicosane, 2,2,4,l 3,15 l S-hexamethyl- 7,l0-bis( 1 ,3,3-trimethylbutyl)hexadecane, 9-hexyl 1 2- octyl-doco
- a cosmetic composition comprising conventional cosmetic agents, the improvement which comprises employing as a non-irritating cosmetic base of said cosmetic composition at least one saturated,
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP47100400A JPS5231022B2 (enrdf_load_stackoverflow) | 1972-10-06 | 1972-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3886287A true US3886287A (en) | 1975-05-27 |
Family
ID=14272921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US363372A Expired - Lifetime US3886287A (en) | 1972-10-06 | 1973-05-24 | Cosmetics containing saturated, branched synthetic higher hydrocarbon |
Country Status (6)
Country | Link |
---|---|
US (1) | US3886287A (enrdf_load_stackoverflow) |
JP (1) | JPS5231022B2 (enrdf_load_stackoverflow) |
DE (1) | DE2327087B2 (enrdf_load_stackoverflow) |
FR (1) | FR2201863B1 (enrdf_load_stackoverflow) |
GB (1) | GB1379013A (enrdf_load_stackoverflow) |
IT (1) | IT1047476B (enrdf_load_stackoverflow) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4183917A (en) * | 1976-12-25 | 1980-01-15 | The Lion Dentifrice Co., Ltd. | Emulsion-type hair conditioner composition |
US4784843A (en) * | 1985-03-01 | 1988-11-15 | Basf Aktiengesellschaft | Dicyclohexylalkanes, their preparation, cosmetic and pharmaceutical formulations containing these compounds, and their use as oil components |
US20040202739A1 (en) * | 2000-06-27 | 2004-10-14 | Crosby Martin G. | Compositions and methods for treating female sexual response |
US20070238909A1 (en) * | 2006-02-03 | 2007-10-11 | Gadewar Sagar B | Continuous process for converting natural gas to liquid hydrocarbons |
US20080171898A1 (en) * | 2004-04-16 | 2008-07-17 | Waycuilis John J | Process for converting gaseous alkanes to liquid hydrocarbons |
US20080200740A1 (en) * | 2004-04-16 | 2008-08-21 | Marathon Oil Company | Process for converting gaseous alkanes to olefins and liquid hydrocarbons |
US20090312586A1 (en) * | 2008-06-13 | 2009-12-17 | Marathon Gtf Technology, Ltd. | Hydrogenation of multi-brominated alkanes |
US7674941B2 (en) | 2004-04-16 | 2010-03-09 | Marathon Gtf Technology, Ltd. | Processes for converting gaseous alkanes to liquid hydrocarbons |
US7838708B2 (en) | 2001-06-20 | 2010-11-23 | Grt, Inc. | Hydrocarbon conversion process improvements |
US7847139B2 (en) | 2003-07-15 | 2010-12-07 | Grt, Inc. | Hydrocarbon synthesis |
US20110015458A1 (en) * | 2009-07-15 | 2011-01-20 | Marathon Gtf Technology, Ltd. | Conversion of hydrogen bromide to elemental bromine |
US7883568B2 (en) | 2006-02-03 | 2011-02-08 | Grt, Inc. | Separation of light gases from halogens |
US7964764B2 (en) | 2003-07-15 | 2011-06-21 | Grt, Inc. | Hydrocarbon synthesis |
US7998438B2 (en) | 2007-05-24 | 2011-08-16 | Grt, Inc. | Zone reactor incorporating reversible hydrogen halide capture and release |
US20110218372A1 (en) * | 2010-03-02 | 2011-09-08 | Marathon Gtf Technology, Ltd. | Processes and systems for the staged synthesis of alkyl bromides |
US8173851B2 (en) | 2004-04-16 | 2012-05-08 | Marathon Gtf Technology, Ltd. | Processes for converting gaseous alkanes to liquid hydrocarbons |
US8273929B2 (en) | 2008-07-18 | 2012-09-25 | Grt, Inc. | Continuous process for converting natural gas to liquid hydrocarbons |
US8282810B2 (en) | 2008-06-13 | 2012-10-09 | Marathon Gtf Technology, Ltd. | Bromine-based method and system for converting gaseous alkanes to liquid hydrocarbons using electrolysis for bromine recovery |
US8367884B2 (en) | 2010-03-02 | 2013-02-05 | Marathon Gtf Technology, Ltd. | Processes and systems for the staged synthesis of alkyl bromides |
US8436220B2 (en) | 2011-06-10 | 2013-05-07 | Marathon Gtf Technology, Ltd. | Processes and systems for demethanization of brominated hydrocarbons |
US8642822B2 (en) | 2004-04-16 | 2014-02-04 | Marathon Gtf Technology, Ltd. | Processes for converting gaseous alkanes to liquid hydrocarbons using microchannel reactor |
US8802908B2 (en) | 2011-10-21 | 2014-08-12 | Marathon Gtf Technology, Ltd. | Processes and systems for separate, parallel methane and higher alkanes' bromination |
US8815050B2 (en) | 2011-03-22 | 2014-08-26 | Marathon Gtf Technology, Ltd. | Processes and systems for drying liquid bromine |
US8829256B2 (en) | 2011-06-30 | 2014-09-09 | Gtc Technology Us, Llc | Processes and systems for fractionation of brominated hydrocarbons in the conversion of natural gas to liquid hydrocarbons |
US9193641B2 (en) | 2011-12-16 | 2015-11-24 | Gtc Technology Us, Llc | Processes and systems for conversion of alkyl bromides to higher molecular weight hydrocarbons in circulating catalyst reactor-regenerator systems |
US9206093B2 (en) | 2004-04-16 | 2015-12-08 | Gtc Technology Us, Llc | Process for converting gaseous alkanes to liquid hydrocarbons |
FR3041254A1 (fr) * | 2015-09-22 | 2017-03-24 | Biosynthis Sarl | Ingredient cosmetique a base d'hydrocarbures satures ramifies |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4368189A (en) * | 1981-08-03 | 1983-01-11 | Eli Lilly And Company | Cosmetic moisturizer formulation |
US4609545A (en) * | 1982-11-24 | 1986-09-02 | Schlossman Mitchell L | Compressing aid for compressing powders |
GB9405320D0 (en) * | 1994-03-18 | 1994-04-27 | Procter & Gamble | Powder cosmetic compositions |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069324A (en) * | 1959-06-19 | 1962-12-18 | Monot Pierre Louis Victor | Hydrogenated tallowperhydrosqualene dermatological excipient |
-
1972
- 1972-10-06 JP JP47100400A patent/JPS5231022B2/ja not_active Expired
-
1973
- 1973-05-18 GB GB2382973A patent/GB1379013A/en not_active Expired
- 1973-05-24 US US363372A patent/US3886287A/en not_active Expired - Lifetime
- 1973-05-28 DE DE2327087A patent/DE2327087B2/de active Granted
- 1973-05-30 IT IT12650/73A patent/IT1047476B/it active
- 1973-06-14 FR FR7321592A patent/FR2201863B1/fr not_active Expired
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069324A (en) * | 1959-06-19 | 1962-12-18 | Monot Pierre Louis Victor | Hydrogenated tallowperhydrosqualene dermatological excipient |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4183917A (en) * | 1976-12-25 | 1980-01-15 | The Lion Dentifrice Co., Ltd. | Emulsion-type hair conditioner composition |
US4784843A (en) * | 1985-03-01 | 1988-11-15 | Basf Aktiengesellschaft | Dicyclohexylalkanes, their preparation, cosmetic and pharmaceutical formulations containing these compounds, and their use as oil components |
US20040202739A1 (en) * | 2000-06-27 | 2004-10-14 | Crosby Martin G. | Compositions and methods for treating female sexual response |
US8128972B2 (en) | 2000-06-27 | 2012-03-06 | Semprae Laboratories, Inc. | Compositions and methods for enhancing and treating female sexual response |
US7875299B2 (en) * | 2000-06-27 | 2011-01-25 | Semprae Laboratories, Inc. | Compositions and methods for enhancing or treating female sexual response |
US7838708B2 (en) | 2001-06-20 | 2010-11-23 | Grt, Inc. | Hydrocarbon conversion process improvements |
US8415512B2 (en) | 2001-06-20 | 2013-04-09 | Grt, Inc. | Hydrocarbon conversion process improvements |
US7847139B2 (en) | 2003-07-15 | 2010-12-07 | Grt, Inc. | Hydrocarbon synthesis |
US7964764B2 (en) | 2003-07-15 | 2011-06-21 | Grt, Inc. | Hydrocarbon synthesis |
US20080171898A1 (en) * | 2004-04-16 | 2008-07-17 | Waycuilis John J | Process for converting gaseous alkanes to liquid hydrocarbons |
US8008535B2 (en) | 2004-04-16 | 2011-08-30 | Marathon Gtf Technology, Ltd. | Process for converting gaseous alkanes to olefins and liquid hydrocarbons |
US20080183022A1 (en) * | 2004-04-16 | 2008-07-31 | Waycuilis John J | Process for converting gaseous alkanes to liquid hydrocarbons |
US9206093B2 (en) | 2004-04-16 | 2015-12-08 | Gtc Technology Us, Llc | Process for converting gaseous alkanes to liquid hydrocarbons |
US20080200740A1 (en) * | 2004-04-16 | 2008-08-21 | Marathon Oil Company | Process for converting gaseous alkanes to olefins and liquid hydrocarbons |
US8232441B2 (en) | 2004-04-16 | 2012-07-31 | Marathon Gtf Technology, Ltd. | Process for converting gaseous alkanes to liquid hydrocarbons |
US7880041B2 (en) | 2004-04-16 | 2011-02-01 | Marathon Gtf Technology, Ltd. | Process for converting gaseous alkanes to liquid hydrocarbons |
US8173851B2 (en) | 2004-04-16 | 2012-05-08 | Marathon Gtf Technology, Ltd. | Processes for converting gaseous alkanes to liquid hydrocarbons |
US7560607B2 (en) | 2004-04-16 | 2009-07-14 | Marathon Gtf Technology, Ltd. | Process for converting gaseous alkanes to liquid hydrocarbons |
US8642822B2 (en) | 2004-04-16 | 2014-02-04 | Marathon Gtf Technology, Ltd. | Processes for converting gaseous alkanes to liquid hydrocarbons using microchannel reactor |
US7674941B2 (en) | 2004-04-16 | 2010-03-09 | Marathon Gtf Technology, Ltd. | Processes for converting gaseous alkanes to liquid hydrocarbons |
US7579510B2 (en) | 2006-02-03 | 2009-08-25 | Grt, Inc. | Continuous process for converting natural gas to liquid hydrocarbons |
US8053616B2 (en) | 2006-02-03 | 2011-11-08 | Grt, Inc. | Continuous process for converting natural gas to liquid hydrocarbons |
US20070238909A1 (en) * | 2006-02-03 | 2007-10-11 | Gadewar Sagar B | Continuous process for converting natural gas to liquid hydrocarbons |
US7883568B2 (en) | 2006-02-03 | 2011-02-08 | Grt, Inc. | Separation of light gases from halogens |
US8921625B2 (en) | 2007-02-05 | 2014-12-30 | Reaction35, LLC | Continuous process for converting natural gas to liquid hydrocarbons |
US7998438B2 (en) | 2007-05-24 | 2011-08-16 | Grt, Inc. | Zone reactor incorporating reversible hydrogen halide capture and release |
US8282810B2 (en) | 2008-06-13 | 2012-10-09 | Marathon Gtf Technology, Ltd. | Bromine-based method and system for converting gaseous alkanes to liquid hydrocarbons using electrolysis for bromine recovery |
US20090312586A1 (en) * | 2008-06-13 | 2009-12-17 | Marathon Gtf Technology, Ltd. | Hydrogenation of multi-brominated alkanes |
US8273929B2 (en) | 2008-07-18 | 2012-09-25 | Grt, Inc. | Continuous process for converting natural gas to liquid hydrocarbons |
US8415517B2 (en) | 2008-07-18 | 2013-04-09 | Grt, Inc. | Continuous process for converting natural gas to liquid hydrocarbons |
US20110015458A1 (en) * | 2009-07-15 | 2011-01-20 | Marathon Gtf Technology, Ltd. | Conversion of hydrogen bromide to elemental bromine |
US9133078B2 (en) | 2010-03-02 | 2015-09-15 | Gtc Technology Us, Llc | Processes and systems for the staged synthesis of alkyl bromides |
US8367884B2 (en) | 2010-03-02 | 2013-02-05 | Marathon Gtf Technology, Ltd. | Processes and systems for the staged synthesis of alkyl bromides |
US20110218372A1 (en) * | 2010-03-02 | 2011-09-08 | Marathon Gtf Technology, Ltd. | Processes and systems for the staged synthesis of alkyl bromides |
US8198495B2 (en) | 2010-03-02 | 2012-06-12 | Marathon Gtf Technology, Ltd. | Processes and systems for the staged synthesis of alkyl bromides |
US8815050B2 (en) | 2011-03-22 | 2014-08-26 | Marathon Gtf Technology, Ltd. | Processes and systems for drying liquid bromine |
US8436220B2 (en) | 2011-06-10 | 2013-05-07 | Marathon Gtf Technology, Ltd. | Processes and systems for demethanization of brominated hydrocarbons |
US8829256B2 (en) | 2011-06-30 | 2014-09-09 | Gtc Technology Us, Llc | Processes and systems for fractionation of brominated hydrocarbons in the conversion of natural gas to liquid hydrocarbons |
US8802908B2 (en) | 2011-10-21 | 2014-08-12 | Marathon Gtf Technology, Ltd. | Processes and systems for separate, parallel methane and higher alkanes' bromination |
US9193641B2 (en) | 2011-12-16 | 2015-11-24 | Gtc Technology Us, Llc | Processes and systems for conversion of alkyl bromides to higher molecular weight hydrocarbons in circulating catalyst reactor-regenerator systems |
FR3041254A1 (fr) * | 2015-09-22 | 2017-03-24 | Biosynthis Sarl | Ingredient cosmetique a base d'hydrocarbures satures ramifies |
WO2017050943A1 (fr) * | 2015-09-22 | 2017-03-30 | Biosynthis | Ingredient cosmetique a base d'hydrocarbures satures ramifies |
KR20180054819A (ko) * | 2015-09-22 | 2018-05-24 | 바이오신디스 | 분지형 포화 탄화수소 화장 성분 |
CN108348789A (zh) * | 2015-09-22 | 2018-07-31 | 碧昂赛恩斯公司 | 支链饱和烃化妆品成分 |
EP3744402A1 (fr) | 2015-09-22 | 2020-12-02 | Biosynthis | Ingredient cosmetique a base d'hydrocarbures satures ramifies |
CN108348789B (zh) * | 2015-09-22 | 2021-09-07 | 碧昂赛恩斯公司 | 支链饱和烃化妆品成分 |
US11571372B2 (en) | 2015-09-22 | 2023-02-07 | Biosynthis | Branched saturated hydrocarbon cosmetic ingredient |
Also Published As
Publication number | Publication date |
---|---|
DE2327087A1 (de) | 1974-04-25 |
FR2201863B1 (enrdf_load_stackoverflow) | 1977-05-06 |
GB1379013A (en) | 1975-01-02 |
DE2327087B2 (de) | 1975-01-16 |
DE2327087C3 (enrdf_load_stackoverflow) | 1975-08-28 |
FR2201863A1 (enrdf_load_stackoverflow) | 1974-05-03 |
IT1047476B (it) | 1980-09-10 |
JPS4955853A (enrdf_load_stackoverflow) | 1974-05-30 |
JPS5231022B2 (enrdf_load_stackoverflow) | 1977-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3886287A (en) | Cosmetics containing saturated, branched synthetic higher hydrocarbon | |
US2054989A (en) | Compositions for application to the human skin | |
CN1875914B (zh) | 化妆品粉末 | |
EP0548694B2 (en) | Oil-based solid cosmetic composition | |
CN100577142C (zh) | 个人护理用组合物 | |
JP2003516949A (ja) | 耐摩耗性化粧組成物 | |
US4110430A (en) | A method of deodorizing | |
BRPI1002978A2 (pt) | composição em forma de emulsão óleo-em-água e processo não terapêutico de cuidado ou de maquilagem das matérias queratìnicas | |
US4268526A (en) | Cosmetic cream formulation | |
JPS60228405A (ja) | スキントリートメント組成物 | |
HK109493A (en) | Water-in-oil-type cosmetic | |
JP2001010925A (ja) | 乳化組成物 | |
HK41993A (en) | Cosmetics comprising an oil-gelling agent | |
US6210694B1 (en) | Cosmetic composition containing charcoal and process for the preparation thereof | |
CA1116525A (en) | Use of alkylene oxide copolymers as emollients in cosmetic preparations | |
US2294229A (en) | Cosmetic preparations | |
US4631295A (en) | Functional oil-cream bath | |
US5209922A (en) | Water soluble polymers having antifungal properties | |
US5106611A (en) | Use of modified diorganopolysiloxanes as antioxidants in cosmetics or in dermatology | |
JPH08231382A (ja) | 浴用組成物 | |
EP0129014A1 (de) | Desodorierendes kosmetisches Mittel | |
JPH05285369A (ja) | 撥水・撥油性粉体及びこれを含有する化粧料 | |
JPH0593153A (ja) | 撥水・撥油性化粧用粉体及び該粉体を含有する化粧料 | |
US3152951A (en) | Germicidal composition of iodine and liquid lanolin | |
JPH0794366B2 (ja) | O/w型ゲル状化粧料の製造方法 |